BAJAJ BROKING

Notification close image
No new Notification messages
card image
Seshaasai Technologies Ltd IPO
Apply for the Seshaasai Technologies Ltd IPO through UPI in Just minutes
delete image
card image
Start your SIP with just ₹100
Choose from 4,000+ Mutual Funds on Bajaj Broking
delete image
card image
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
delete image
card image
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
delete image
card image
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.
delete image
Active
SME

Curis Lifesciences Ltd

Apply Now

Curis Lifesciences Ltd IPO Details

IPO Date

07 Nov 2025 - 11 Nov 2025

Listing Date

14 Nov 2025

Face Value

10

Price

₹120 - ₹128 per share

Lot Size

1 Lot (2000 Shares)

Listing At

NSE-SME

Employee Discount

₹0 per share

Issue Type

Book Building - SME

Minimum Investment

₹2,56,000 / 2 Lot

Maximum Investment

₹2,56,000 / 2 Lot

Total Issue Size

₹27.52 Crores

Fresh Issue

₹27.52 Crores

Offer For Sale

NA

Retail Discount

₹0

Shareholding Pre Issue

59,34,434 Shares

Shareholding Post Issue

80,84,434 Shares

info

Schedule

    Here are the important dates you need to know in order to participate in this IPO

tick

Bidding starts

7th Nov

tick

Bidding ends

11th Nov

tick

Allotment of shares

12th Nov

tick

Initiation of refund

13th Nov

tick

Credit of shares to Demat account

13th Nov

tick

Listing date

14th Nov

About Curis Lifesciences Ltd IPO

Incorporated in 2010, Curis Lifesciences Limited is a pharmaceutical company engaged in developing, manufacturing, and distributing a diverse portfolio of healthcare products. The company’s operations span both domestic and international markets, focusing on the production of general pharmaceutical tablets, capsules, oral liquids, external preparations, and sterile ophthalmic ointments. Curis Lifesciences caters to a wide client base, serving over 100 corporate customers through loan licence and contract manufacturing arrangements, while also promoting its own brands in markets such as Yemen and Kenya. Its modern manufacturing facility in Sanand, Gujarat, is equipped with advanced technology and follows strict quality control standards to maintain consistency and safety across all products.
 

The company’s business model is divided into three main categories — loan licence manufacturing, contract manufacturing, and direct export or own brand marketing. Under the loan licence vertical, clients provide raw materials, excipients, and necessary documentation, while Curis Lifesciences undertakes the production process under the supervision of a customer-appointed chemist. This model ensures flexibility and compliance with client requirements. The company employs 95 permanent staff as of July 31, 2025, and continues to strengthen its position in the pharmaceutical industry by combining manufacturing expertise with adherence to regulatory standards and customer-oriented practices.

Shareholder Pattern

  Pre-Issue Post-Issue
Promoter Group 92.68% 68.03%
Public Group 7.32% 31.97%

Curis Lifesciences Ltd IPO Reservation

QIB Shares Offered 4,08,000 (18.98%)
NII (HNI) Shares Offered 3,08,000 (14.33%)
Retail Shares Offered 7,16,000 (33.3%)
Anchor Investor Shares Offered 6,10,000 (28.37%)
Total Shares Offered 21,50,000
Total Shares With Anchor Investor 21,50,000

Curis Lifesciences Ltd IPO Lot Size

Application Lots Shares Amount
Retail (Min) 2 2,000 ₹2,56,000
Retail (Max) 2 2,000 ₹2,56,000
S HNI (Min) 3 3,000 ₹3,84,000
S HNI (Max) 7 7,000 ₹8,96,000
B HNI (MIN) 8 8,000 ₹10,24,000

Curis Lifesciences Ltd IPO Anchor Investor Details

Bid Date November 06, 2025
Shares Offered 6,09,000
Anchor Investment Details 7.7952

Curis Lifesciences Ltd IPO registrar

MUFG Intime India Pvt Ltd
Phone Number +91 810 811 4949;
Email Id curislifesciences.smeipo@in.mpms.mufg.com
Our Website www.linkintime.co.in

Curis Lifesciences Ltd IPO Lead Manager

1. Finaax Capital Advisors Private Limited

Curis Lifesciences Ltd Financial Information

March 31, March 31, March 31,
Net Worth
Reserves and Surplus
Total Borrowing

Curis Lifesciences Ltd IPO Subscription LIVE Status

Category No. of shares offered No. of shares bid No. of subscribed
Qualified Institutional Buyers (QIBs) 0 34,12,000 0
Non Institutional Investors (NIIs) 4,16,000 3,67,000 0.8822
NII(Bid amount of more than Ten Lakh Rupees) 2,05,333 3,16,000 1.539
NII(Bid amount of more than 2 Lakh < 10 Rupees) 1,02,667 51,000 0.4968
Retail Individual Investors (RIIs) 7,16,000 6,04,000 0.8436
Total 15,41,000 43,83,000 2.8443

Strength of Curis Lifesciences Ltd

  • Experienced Promoters and Management Team.
  • Wide range of Products.
  • Strategic Location of Manufacturing Facility.
  • Scalable Business Model.
  • Quality assurance.

Risks Involved

  • Our manufacturing facility is concentrated in Sanand, Ahmedabad, Gujarat, exposing us to risks from economic, regulatory, political, and other regional changes, including natural disasters, which could negatively impact our business operations, financial performance, and overall condition.
  • As a pharmaceutical company, we operate in a highly regulated industry where our business relies on obtaining approvals from relevant regulatory and health authorities. Delays or failures in securing or renewing these essential approvals, registrations, or changes in the regulatory environment for marketing our products in regulated markets could have a significant impact on our business and strategy, ultimately affecting our overall profitability.
  • Our business operations are subject to fluctuations in raw material prices.
  • The company relies on a limited number of customers for its sales, and the loss of any major customer could adversely impact our revenue and profitability.
  • The company relies on a limited number of suppliers for product procurement, and the loss of any key supplier could impact our business operations.
  • We depend on a limited number of States for a significant portion of our revenue from operations. The loss of any of our major customer in this States due to any adverse development or significant reduction in business from our major customer may adversely affect our business, financial condition, results of operations and future prospects.
  • Our Company is dependent on a few countries. Loss of any of these large countries may affect our business operations.
  • Our Company depends on some of our Products which contributes 100% of the total revenue of the company. The loss of any of this major Products due to any adverse development or significant reduction in business from our major customer may adversely affect our business, financial condition, results of operations and future prospects.
  • The Statutory Auditor and the Peer Review Auditor of the company are not same.
  • There are certain discrepancies/errors which have occurred in some of our corporate secretarial records relating to forms filed with the RoC and other provisions of Companies Act, 2013. Any penalty or action taken by any regulatory authorities in future.
stock

Invest in IPOs with ease

Sign-in to invest with your demat account, or set up a new demat account for free

Industry Outlook of Curis Lifesciences IPO

  • The Indian pharmaceutical industry is recognised globally for producing generic medicines and affordable vaccines. Over time, it has evolved into a key sector, ranking third globally by volume and 14th by value, contributing about 1.72% to India’s GDP.

  • According to ICRA, the industry is expected to record a growth rate of around 9–11% in FY2024.

  • In FY2023, the Indian pharma market achieved nearly 5% year-on-year growth, touching approximately USD 49.78 billion. Between FY2018 and FY2023, the industry maintained a compound annual growth rate (CAGR) of 6–8%, mainly supported by an 8% rise in exports and a 6% growth in domestic demand.

  • The key segments within the pharmaceutical sector include generic medicines, over-the-counter (OTC) drugs, active pharmaceutical ingredients (APIs) or bulk drugs, vaccines, contract research and manufacturing services (CRAMS), and biosimilars and biologics.

  • The market size of the Indian pharmaceutical sector continues to expand steadily.

Interested in more opportunities? Check out our Upcoming IPO section for new listings and don’t forget to check your IPO allotment status for Curis Lifesciences IPO.

Explore Other IPOs

  • Current IPOs
  • Upcoming IPOs
  • Closed IPOs
  • IPO Performance
  • All
  • MainBoard
  • SME
Mahamaya Lifesciences Limited IPO
Bidding Period
11th Nov 2025 - 11th Nov 2025
Price Range
₹108.0 - 114.0
IPO Size
₹0
Workmates Core2cloud Solution Limited IPO
Bidding Period
11th Nov 2025 - 11th Nov 2025
Price Range
₹200.0 - 204.0
IPO Size
₹0
Tenneco Clean Air India Limited IPO
Bidding Period
12th Nov 2025 - 11th Nov 2025
Price Range
₹378.0 - 397.0
IPO Size
₹0
Aarvee Engineering Consultants Limited IPO
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
Aastha Spintex Limited IPO
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
Advanced SysTek Limited IPO
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
Advit Jewels Limited IPO
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
Aequs Limited IPO
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
Aggcon Equipments International Limited IPO
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
Agilus Diagnostics Limited IPO
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
Airox Technologies Limited IPO
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
Ajay Poly Limited IPO
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
Alcobrew Distilleries India Limited IPO
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
Allchem Lifescience Limited IPO
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
Allied Engineering Works Limited IPO
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
Alpine Texworld Limited IPO
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
Amagi Media Labs Limited IPO
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
Amir Chand Jagadish Kumar Exports Limited IPO
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
Annu Projects Limited IPO
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
AOne Steels India Limited IPO
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
NO ACTIVE IPO HERE
  • All
  • MainBoard
  • SME
BILLIONBRAINS GARAGE VENTURES LIMITED IPO
Bidding Period
4th Nov 2025 - 11th Nov 2025
Price Range
₹95.0 - 100.0
IPO Size
₹66,32,30,00,000
SHREEJI GLOBAL FMCG LIMITED IPO
Bidding Period
4th Nov 2025 - 11th Nov 2025
Price Range
₹120.0 - 125.0
IPO Size
₹85,00,00,000
LENSKART SOLUTIONS LIMITED IPO
Bidding Period
31st Oct 2025 - 11th Nov 2025
Price Range
₹382.0 - 402.0
IPO Size
₹72,78,02,00,000
STUDDS ACCESSORIES LIMITED IPO
Bidding Period
30th Oct 2025 - 11th Nov 2025
Price Range
₹557.0 - 585.0
IPO Size
₹4,55,49,00,000
ORKLA INDIA LIMITED IPO
Bidding Period
29th Oct 2025 - 10th Oct 2025
Price Range
₹695.0 - 730.0
IPO Size
₹16,67,54,00,000
SAFECURE SERVICES LIMITED IPO
Bidding Period
29th Oct 2025 - 10th Oct 2025
Price Range
₹102.0 - 102.0
IPO Size
₹30,60,00,000
GAME CHANGERS TEXFAB LIMITED IPO
Bidding Period
28th Oct 2025 - 10th Oct 2025
Price Range
₹96.0 - 102.0
IPO Size
₹54,84,00,000
JAYESH LOGISTICS LIMITED IPO
Bidding Period
27th Oct 2025 - 10th Oct 2025
Price Range
₹116.0 - 122.0
IPO Size
₹28,64,00,000
MIDWEST LIMITED IPO
Bidding Period
15th Oct 2025 - 10th Oct 2025
Price Range
₹1014.0 - 1065.0
IPO Size
₹4,51,00,00,000
CANARA HSBC LIFE INSURANCE COMPANY LIMITED IPO
Bidding Period
10th Oct 2025 - 10th Oct 2025
Price Range
₹100.0 - 106.0
IPO Size
₹25,17,50,00,000
SIHORA INDUSTRIES LIMITED IPO
Bidding Period
10th Oct 2025 - 10th Oct 2025
Price Range
₹66.0 - 66.0
IPO Size
₹10,56,00,000
SK MINERALS AND ADDITIVES LIMITED IPO
Bidding Period
10th Oct 2025 - 10th Oct 2025
Price Range
₹120.0 - 127.0
IPO Size
₹41,15,00,000
SHLOKKA DYES LIMITED IPO
Bidding Period
30th Sep 2025 - 10th Oct 2025
Price Range
₹88.0 - 91.0
IPO Size
₹60,33,00,000
CANARA ROBECO ASSET MANAGEMENT COMPANY LIMITED IPO
Bidding Period
9th Oct 2025 - 10th Oct 2025
Price Range
₹253.0 - 266.0
IPO Size
₹13,26,13,00,000
RUBICON RESEARCH LIMITED IPO
Bidding Period
9th Oct 2025 - 10th Oct 2025
Price Range
₹461.0 - 485.0
IPO Size
₹13,77,50,00,000
MITTAL SECTIONS LIMITED IPO
Bidding Period
7th Oct 2025 - 10th Oct 2025
Price Range
₹136.0 - 143.0
IPO Size
₹52,91,00,000
LG ELECTRONICS INDIA LIMITED IPO
Bidding Period
7th Oct 2025 - 10th Oct 2025
Price Range
₹1080.0 - 1140.0
IPO Size
₹1,16,07,01,00,000
TATA CAPITAL LIMITED IPO
Bidding Period
6th Oct 2025 - 10th Oct 2025
Price Range
₹310.0 - 326.0
IPO Size
₹1,55,11,87,00,000
WEWORK INDIA MANAGEMENT LIMITED IPO
Bidding Period
3rd Oct 2025 - 10th Oct 2025
Price Range
₹615.0 - 648.0
IPO Size
₹30,00,00,00,000
NSB BPO SOLUTIONS LIMITED IPO
Bidding Period
23rd Sep 2025 - 10th Oct 2025
Price Range
₹121.0 - 140.0
IPO Size
₹74,20,00,000
  • All
  • MainBoard
  • SME
STUDDS ACCESSORIES LIMITED IPO
Issue Prize
585.00
Listing Day Close
560.45(-4.27%)
ORKLA INDIA LIMITED IPO
Issue Prize
730.00
Listing Day Close
713.40(-2.33%)
SAFECURE SERVICES LIMITED IPO
Issue Prize
102.00
Listing Day Close
77.55(-23.53%)
GAME CHANGERS TEXFAB LIMITED IPO
Issue Prize
102.00
Listing Day Close
109.35(6.86%)
JAYESH LOGISTICS LIMITED IPO
Issue Prize
122.00
Listing Day Close
117.80(-3.28%)
MIDWEST LIMITED IPO
Issue Prize
1065.00
Listing Day Close
1141.10(7.14%)
CANARA HSBC LIFE INSURANCE COMPANY LIMITED IPO
Issue Prize
106.00
Listing Day Close
111.50(5.66%)
SIHORA INDUSTRIES LIMITED IPO
Issue Prize
66.00
Listing Day Close
66.50(1.52%)
SK MINERALS AND ADDITIVES LIMITED IPO
Issue Prize
127.00
Listing Day Close
152.25(19.69%)
SHLOKKA DYES LIMITED IPO
Issue Prize
91.00
Listing Day Close
85.50(-5.49%)
CANARA ROBECO ASSET MANAGEMENT COMPANY LIMITED IPO
Issue Prize
266.00
Listing Day Close
300.25(12.78%)
RUBICON RESEARCH LIMITED IPO
Issue Prize
485.00
Listing Day Close
627.45(29.28%)
MITTAL SECTIONS LIMITED IPO
Issue Prize
143.00
Listing Day Close
108.70(-23.78%)
LG ELECTRONICS INDIA LIMITED IPO
Issue Prize
1140.00
Listing Day Close
1689.40(48.16%)
TATA CAPITAL LIMITED IPO
Issue Prize
326.00
Listing Day Close
330.40(1.23%)
WEWORK INDIA MANAGEMENT LIMITED IPO
Issue Prize
648.00
Listing Day Close
624.75(-3.55%)
NSB BPO SOLUTIONS LIMITED IPO
Issue Prize
140.00
Listing Day Close
121.30(-13.57%)
GREENLEAF ENVIROTECH LIMITED IPO
Issue Prize
136.00
Listing Day Close
132.90(-2.21%)
DSM FRESH FOODS LIMITED IPO
Issue Prize
100.00
Listing Day Close
126.00(26.00%)
SHEEL BIOTECH LIMITED IPO
Issue Prize
63.00
Listing Day Close
95.55(52.38%)

Frequently Asked Questions

What is Curis Lifesciences Ltd IPO?

Answer Field

Curis Lifesciences Ltd IPO is a SME IPO of 21,50,000 equity shares of a face value of ₹10 aggregating up to ₹27.52 Crores. The issue is priced at ₹120 to ₹128 per share. The minimum order quantity is 2000 Shares. The IPO opens on November 07, 2025, and closes on November 11, 2025. MUFG Intime India Pvt Ltd is the registrar for the IPO. The shares are proposed to be listed on NSE-SME.

When Curis Lifesciences Ltd IPO will open?

Answer Field

The Curis Lifesciences Ltd IPO opens on November 07, 2025 and closes on November 11, 2025.

What is the lot size of Curis Lifesciences Ltd?

Answer Field

Curis Lifesciences Ltd lot size is 2000 shares, and the minimum amount required is ₹2,56,000.

How to apply for Curis Lifesciences Ltd IPO?

Answer Field

You can apply in Curis Lifesciences Ltd IPO online using either UPI or ASBA as payment method. ASBA IPO application is available in the net banking of your bank account. UPI IPO application is offered by brokers who don't offer banking services. To apply for an IPO:

• Login to Bajaj Broking account App/Website & click on IPO

• Enter the number of lots and price at which you wish to apply.

• Enter your UPI ID and click on submit. With this, your bid will be placed with the exchange.

• You will receive a mandate notification to block funds in your UPI app.

• Approve the mandate request on your UPI and funds will be blocked.

When is Curis Lifesciences Ltd IPO allotment?

Answer Field

The finalization of Basis of Allotment for Curis Lifesciences Ltd IPO will be done on November 12, 2025, and the allotted shares will be credited to your demat account by November 13, 2025.

When is Curis Lifesciences Ltd IPO listing date?

Answer Field

The Curis Lifesciences Ltd listing date is November 14, 2025.

Who is the registrar of Curis Lifesciences Ltd IPO?

Answer Field

The registrar of Curis Lifesciences Ltd IPO is MUFG Intime India Pvt Ltd

Which company is the book-running lead manager of the IPO?

Answer Field

Finaax Capital Advisors Private Limited will be the book-running lead manager of this IPO.

What is the fresh issue of Curis Lifesciences Ltd IPO?

Answer Field

The fresh issue size is ₹27.52 Crores equity shares.

What minimum lot size can retail subscribers subscribe to Curis Lifesciences Ltd?

Answer Field

Retail investors can subscribe to a minimum of one lot, 2000 shares and ₹2,56,000 amount.

How can I approve the UPI mandate request for Curis Lifesciences Ltd IPO?

Answer Field

To apply for Curis Lifesciences Ltd IPO, you need to log in to your demat account to complete the bidding process. Then, approve the payment mandate on your UPI app.

What is the price range of Curis Lifesciences Ltd?

Answer Field

The price of each Curis Lifesciences Ltd share will be ranging in between ₹120 to ₹128 per share.

What is the cut-off time for the UPI mandate for Curis Lifesciences Ltd IPO?

Answer Field

The cut-off time for the UPI mandate confirmation is 5:00 PM, November 11, 2025.

No results found

banner-icon

Open Your Free Demat Account

Enjoy zero brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy zero brokerage on delivery trades

+91

|